Introduction: Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), poses a significant health burden worldwide, leading to considerable morbidity and mortality. Effective prevention and management strategies for VTE are critical, especially given the associated risk factors and implications, including those linked with COVID-19. Timely diagnosis and intervention play pivotal roles in mitigating the impact of VTE on patient outcomes. Method: This integrative review aimed to synthesize findings from studies investigating interventions for VTE prevention and management. A comprehensive search strategy was employed to identify relevant literature, and data analysis involved descriptive statistics, comparative analysis of intervention effectiveness, and qualitative synthesis to identify common themes and trends across studies. Results: The review included studies examining diverse interventions for VTE prevention and management. These interventions ranged from routine duplex ultrasound screening to novel mechanical compression devices and oxygen therapy in intermediate-risk acute PE. Through the studies, interventions demonstrated efficacy in reducing VTE rates, improving compliance, and enhancing patient outcomes. Notable findings included the significant reduction in VTE rates with fondaparinux combined with intermittent pneumatic compression compared to IPC alone and the improved compliance with mechanical prophylaxis using novel mechanical compression devices. Conclusion: The review underscores the importance of diverse interventions in the prevention and management of VTE. While the evidence supports the effectiveness of these interventions, further research, including larger-scale trials, is warranted to validate findings and optimize patient care. This multidisciplinary approach to VTE management reflects a continued commitment to improving outcomes and addressing the global burden of this condition.
References
[1]
Ortel, T.L. (2020) Introduction to a Review Series on Treatment of Venous Thrombotic Disorders. Blood, 135, 299-300. https://doi.org/10.1182/blood.2019004079
[2]
Urabe, F., Kimura, S., Iwatani, K., Yasue, K., Koike, Y., Tashiro, K., et al. (2021) The Impact of ABO Blood Type on Developing Venous Thromboembolism in Cancer Patients: Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 10, Article 3692. https://doi.org/10.3390/jcm10163692
[3]
Zhang, H. and Wang, X. (2021) Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Frontiers in Medicine, 8, Article 693927. https://doi.org/10.3389/fmed.2021.693927
[4]
Akamine, A., Takahira, N., Kuroiwa, M., Tomizawa, A. and Atsuda, K. (2022) Venous Thromboembolism Risk Factors and Usefulness of a Risk Scoring System in Lower Limb Orthopedic Surgery: A Case-Control Study in Japan. Medicine, 101, e28622. https://doi.org/10.1097/md.0000000000028622
[5]
Bertoletti, L., Mismetti, V. and Giannakoulas, G. (2020) Use of Anticoagulants in Patients with Pulmonary Hypertension. Hämostaseologie, 40, 348-355. https://doi.org/10.1055/a-1171-3995
[6]
Weiss, A., Frisch, C., Hornung, R., Baubin, M. and Lederer, W. (2021) A Retrospective Analysis of Fibrinolytic and Adjunctive Antithrombotic Treatment during Cardiopulmonary Resuscitation. Scientific Reports, 11, Article No. 24095. https://doi.org/10.1038/s41598-021-03580-6
[7]
Ehrlinder, H., Orsini, N., Modig, K., Wallén, H. and Gigante, B. (2022) Antithrombotic Treatment Switching in Elderly Patients with Atrial Fibrillation and the Risk of Thromboembolism, Bleeding, and Cardiac Death. Research and Practice in Thrombosis and Haemostasis, 6, e12823. https://doi.org/10.1002/rth2.12823
[8]
Blewer, A.L., Ho, A.F.W., Shahidah, N., White, A.E., Pek, P.P., Ng, Y.Y., et al. (2020) Impact of Bystander-Focused Public Health Interventions on Cardiopulmonary Resuscitation and Survival: A Cohort Study. The Lancet Public Health, 5, e428-e436. https://doi.org/10.1016/s2468-2667(20)30140-7
[9]
Moon, S., Ryoo, H.W., Ahn, J.Y., Park, J.B., Lee, D.E., Kim, J.H., et al. (2019) A 5-Year Change of Knowledge and Willingness by Sampled Respondents to Perform Bystander Cardiopulmonary Resuscitation in a Metropolitan City. PLOS ONE, 14, e0211804. https://doi.org/10.1371/journal.pone.0211804
[10]
Kose, N. and Bilgin, F. (2021) Successful Treatment of a Patient with Cardiac Arrest Due to Hyperkalemia by Prolonged Cardiopulmonary Resuscitation along with Hemodialysis: A Case Report and Review of the Literature. Medicina, 57, Article 810. https://doi.org/10.3390/medicina57080810
[11]
Kawasaki, K., Torisu, T., Esaki, M., Eizuka, M., Kawatoko, S., Kumei, T., et al. (2023) Continuous Use of Antithrombotic Medications during Peri-Endoscopic Submucosal Dissection Period for Colorectal Lesions: A Propensity Score Matched Study. Journal of Gastroenterology and Hepatology, 38, 955-961. https://doi.org/10.1111/jgh.16149
[12]
Bonsu, K.O., Young, S., Lee, T., Nguyen, H. and Chitsike, R. (2022) Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada—A Cross-Sectional Survey. Patient Preference and Adherence, 16, 1771-1780. https://doi.org/10.2147/ppa.s367105
[13]
Svedung Wettervik, T., Lenell, S., Enblad, P. and Lewén, A. (2021) Pre-Injury Antithrombotic Agents Predict Intracranial Hemorrhagic Progression, but Not Worse Clinical Outcome in Severe Traumatic Brain Injury. Acta Neurochirurgica, 163, 1403-1413. https://doi.org/10.1007/s00701-021-04816-0
